期刊
LAB ON A CHIP
卷 9, 期 10, 页码 1385-1394出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/b901377f
关键词
-
类别
资金
- Nanobiotechnology Center
- NSF (National Science Foundation),
- CNF (Cornell Nanoscale Science and Technology Facility),
- Army Corp. of Engineers (CERL) [W9132T-07]
- Samsung Lee Kun Hee Scholarship Foundation
A microfluidic device with 3-D hydrogel cell cultures has been developed to test the cytotoxicity of anti-cancer drugs while reproducing multi-organ interactions. In this device, a micro cell Culture analog (mu CCA), cells embedded in 3-D hydrogels are cultured in separate chambers representing the liver, tumor, and marrow, which are connected by channels mimicking blood flow. While the microfluidic network provides a platform for mimicking the pharmacokinetic and pharmacodynamic profiles of a drug in humans, the 3-D hydrogel provides a more physiologically realistic environment to mimic the tissue than monolayer culture. Colon cancer cells (HCT-116) and hepatoma cells (HepG2/C3A) were encapsulated in Matrigel and cultured in the tumor and the liver chamber in a mu CCA, respectively. Myeloblasts (Kasumi-1) were encapsulated in alginate in the marrow chamber; a stiffer hydrogel was necessary to prevent cell migration out of the matrix. The cytotoxic effect of Tegalur, an oral prodrug of 5-fluororacil (5-FU), oil each cell line was tested using the mu CCA with cell-embedded hydrogel. The comparison of experimental results using a 96-well microtiter plate and a mu CCA demonstrated that the mu CCA was able to reproduce the metabolism of Tegafur to 5-FU in the liver and consequent death of cells by 5-FU, while the cultures in a 96-well microtiter plate were unable to do so. The mu CCA utilizing 3-D hydrogel Cell Cultures has potential as a platform for pharmacokinetic-based drug screening in a more physiologically realistic environment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据